South Korea Orders Sanofi-Aventis To Recall Contaminated Heparin
This article was originally published in PharmAsia News
Executive Summary
TOKYO - South Korea's food and drug protection agency announced it has ordered the local unit of French drug maker Sanofi-Aventis SA to recall its top-selling heparin drug after finding an unspecified amount of impure material in the product